SUNY Upstate University Hospital is currently seeking immunity from federal antitrust merger oversight and enforcement of its proposed merger with Crouse Hospital, also in Syracuse. The two merging hospitals applied for a certificate of public advantage without announcement, according to the publication, which would allow the state to approve the merger without a Federal Trade Commission investigation to determine the merger’s impact on a loss of competition. If approved, the state’s health department would monitor the merger instead.
This is the first time a certificate of public advantage has been filed in the state for a hospital merger.
United University Professions president Fred Kowal, PhD, said he is uncomfortable with the hospital’s move and believes the merger will cause loss of competition, The Post-Standard said.
“I think there was legitimate concern on the part of leadership at Upstate who came to the conclusion that this merger might not fly with the FTC,” Dr. Kowal told the publication.
If approved, Syracuse would only have two health systems, and Upstate would have 71 percent of the city’s inpatient market.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.